Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$680M |
| 2 |
Microsoft
MSFT
|
+$506M |
| 3 |
UnitedHealth
UNH
|
+$393M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$381M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$348M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.24B |
| 2 |
Tesla
TSLA
|
+$450M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$444M |
| 4 |
TSMC
TSM
|
+$432M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$371M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 1.79% |
| 2 | Consumer Discretionary | 0.82% |
| 3 | Financials | 0.79% |
| 4 | Healthcare | 0.66% |
| 5 | Industrials | 0.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11876
PUT
Horizon Technology Finance
HRZN
$321M
| $85K | ﹤0.01% |
+11,800
| New | +$91.9K |
|
11877
Fortress Biotech
FBIO
$93.7M
| $84.9K | ﹤0.01% |
+45,635
| New | +$79K |
|
11878
PUT
908 Devices
MASS
$429M
| $84.8K | ﹤0.01% |
11,900
-53,100
| -82% | -$295K |
|
|
BHR
11879
CALL
Braemar Hotels & Resorts
BHR
$141M
| $84.8K | ﹤0.01% |
34,600
+4,700
| +16% | +$10.3K |
|
11880
CareCloud
CCLD
$112M
| $84.7K | ﹤0.01% |
35,894
+14,041
| +64% | +$26.7K |
|
11881
PUT
Babcock & Wilcox
BW
$1.12B
| $84.6K | ﹤0.01% |
88,100
+32,300
| +58% | +$22K |
|
11882
PUT
Douglas Elliman
DOUG
$171M
| $84.4K | ﹤0.01% |
+36,400
| New | +$77.7K |
|
11883
Torrid Holdings
CURV
$218M
| $84K | ﹤0.01% |
28,484
+123
| +0.4% | +$644 |
|
11884
CALL
Allogene Therapeutics
ALLO
$705M
| $83.7K | ﹤0.01% |
74,100
-53,900
| -42% | -$71.6K |
|
|
MODV
11885
PUT
DELISTED
ModivCare
MODV
| $83.6K | ﹤0.01% |
+26,800
| New | +$49.3K |
|
|
SRG
11886
CALL
Seritage Growth Properties
SRG
$119M
| $83.5K | ﹤0.01% |
27,100
+12,900
| +91% | +$37.2K |
|
11887
PUT
IHS Holding
IHS
$2.83B
| $83.4K | ﹤0.01% |
+15,000
| New | +$80.7K |
|
|
TOKE
11888
DELISTED
Cambria Cannabis ETF
TOKE
| $83.3K | ﹤0.01% |
18,590
-313
| -2% | -$1.41K |
|
11889
CALL
Milestone Pharmaceuticals
MIST
$147M
| $83.2K | ﹤0.01% |
42,900
-149,400
| -78% | -$199K |
|
11890
PUT
Lexicon Pharmaceuticals
LXRX
$1.03B
| $83.1K | ﹤0.01% |
87,500
+73,200
| +512% | +$47.4K |
|
|
SATX
11891
DELISTED
SatixFy Communications
SATX
| $83.1K | ﹤0.01% |
+28,357
| New | +$68.5K |
|
|
SHCO
11892
CALL
DELISTED
Soho House & Co
SHCO
| $83.1K | ﹤0.01% |
11,300
-113,000
| -91% | -$702K |
|
11893
Mobile Infrastructure Corp
BEEP
$125M
| $83K | ﹤0.01% |
18,331
+6,452
| +54% | +$26K |
|
11894
Algonquin Power & Utilities
AQN
$4.4B
| $83K | ﹤0.01% |
14,479
-280,267
| -95% | -$1.54M |
|
|
FT
11895
Franklin Universal Trust
FT
$195M
| $82.9K | ﹤0.01% |
10,876
+864
| +9% | +$6.39K |
|
11896
PUT
CPI Aerostructures
CVU
$70.1M
| $82.6K | ﹤0.01% |
+23,600
| New | +$76.2K |
|
|
MAXN
11897
DELISTED
Maxeon Solar Technologies
MAXN
| $82.5K | ﹤0.01% |
+26,959
| New | +$83.9K |
|
11898
Ampco-Pittsburgh
AP
$184M
| $82.3K | ﹤0.01% |
27,807
+16,341
| +143% | +$42.4K |
|
11899
CervoMed
CRVO
$40.1M
| $82.2K | ﹤0.01% |
+13,075
| New | +$111K |
|
11900
Serina Therapeutics
SER
$66.8M
| $81.5K | ﹤0.01% |
+13,237
| New | +$75.2K |
|
Similar funds
Jeff Yass's Q2 2025 Portfolio in Review
As of Q2 2025, Jeff Yass held 14,080 positions worth $720B, up 23% from $586B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Jeff Yass deployed $32.3B of net new capital in Q2 2025, opening 1,720 new positions and adding to 5,716 existing holdings. Its largest new stake was iShares Core MSCI Total International Stock ETF: 1,549,778 shares worth $120M.
By sector, the portfolio is most concentrated in Technology at 1.8% of assets, up from 1.6% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $5.24B trimmed.
- Jeff Yass's largest Q2 2025 buy was iShares Core MSCI Total International Stock ETF: 1,549,778 shares worth $120M.
- Jeff Yass added most to Apple in Q2 2025, an estimated $680M increase.
- Jeff Yass's biggest Q2 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.24B.
- Jeff Yass fully exited Vanguard Intermediate-Term Bond ETF in Q2 2025, selling an estimated $61.8M.
- Jeff Yass's ten largest holdings make up 26% of its $720B portfolio in Q2 2025.
- Jeff Yass opened 1,720 new positions and closed 1,538 in Q2 2025.
- Jeff Yass's portfolio value rose 23% quarter-over-quarter to $720B.
Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.